E-LIB Suche - Ergebnisse für: Keshavan, Nandaki

1

Mission possible: Gene therapy for inherited metabolic dise..:

Baruteau, Julien ; Keshavan, Nandaki ; Venditti, Charles P.
Journal of Inherited Metabolic Disease. 47 (2024) 1 - p. 5-6 , 2024

Link: https://doi.org/10.1002/..

2

Gene therapy for mitochondrial disorders:

Keshavan, Nandaki ; Minczuk, Michal ; Viscomi, Carlo.
Journal of Inherited Metabolic Disease. 47 (2024) 1 - p. 145-175 , 2024

Link: https://doi.org/10.1002/..

3

Expanding the phenotypic spectrum of BCS1L‐related mitochon..:

Hikmat, Omar ; Isohanni, Pirjo ; Keshavan, Nandaki...
Annals of Clinical and Translational Neurology. 8 (2021) 11 - p. 2155-2165 , 2021

Link: https://doi.org/10.1002/..

4

Clinical status, biochemical profile and management of a si..:

Keshavan, Nandaki ; Wood, Michelle ; Alderson, Lucy M....
JIMD Reports. 63 (2021) 2 - p. 123-130 , 2021

Link: https://doi.org/10.1002/..

5

Safety of drug use in patients with a primary mitochondrial..:

De Vries, Maaike C. ; Brown, David A. ; Allen, Mitchell E....
Journal of Inherited Metabolic Disease. 43 (2020) 4 - p. 800-818 , 2020

Link: https://doi.org/10.1002/..

6

Comment on "A severe linezolid‐induced rhabdomyolysis and l..:

Bindoff, Laurence A. ; Brown, David A. ; Gorman, Gráinne S....
Journal of Inherited Metabolic Disease. 44 (2020) 1 - p. 6-7 , 2020

Link: https://doi.org/10.1002/..

7

Moving towards clinical trials for mitochondrial diseases:

Pitceathly, Robert D.S. ; Keshavan, Nandaki ; Rahman, Joyeeta.
Journal of Inherited Metabolic Disease. 44 (2020) 1 - p. 22-41 , 2020

Link: https://doi.org/10.1002/..

8

The natural history of infantile mitochondrial DNA depletio..:

Keshavan, Nandaki ; Abdenur, Jose ; Anderson, Glenn...
Genetics in Medicine. 22 (2020) 1 - p. 199-209 , 2020

Link: https://doi.org/10.1038/..

9

A nutrient-sensitive restriction point is active during ret..:

Love, Nicola K. ; Keshavan, Nandaki ; Lewis, Rebecca..
Development. 141 (2014) 3 - p. 697-706 , 2014

Link: https://doi.org/10.1242/..

10

Clinical status, biochemical profile and management of a si..:

Keshavan, Nandaki ; Wood, Michelle ; Alderson, Lucy M...
https://discovery.ucl.ac.uk/id/eprint/10145373/1/JIMD%20Reports%20-%202022%20-%20Keshavan.pdf. , 2022

Link: https://discovery.ucl.ac..

11

Expanding the phenotypic spectrum of BCS1L‐related mitochon..:

Hikmat, Omar ; Isohanni, Pirjo ; Keshavan, Nandaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607453/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Expanding the phenotypic spectrum of BCS1L-related mitochon..:

Hikmat, Omar ; Isohanni, Pirjo ; Keshavan, Nandaki...
urn:issn:2328-9503. , 2021

Link: https://hdl.handle.net/1..

13

Expanding the phenotypic spectrum of BCS1L-related mitochon..:

Hikmat, Omar ; Isohanni, Pirjo ; Keshavan, Nandaki...
10.1002/acn3.51470. , 2021

Link: http://hdl.handle.net/10..

14

Cardiac valve involvement in ADAR -related type I interfero..:

Crow, Yanick ; Keshavan, Nandaki ; Barbet, Jacques Patrick...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jmedgenet-2019-106457. , 2020

Link: https://pasteur.hal.scie..

15

Safety of drug use in patients with a primary mitochondrial..:

De Vries, Maaike C ; Brown, David A ; Allen, Mitchell E...
urn:issn:0141-8955. , 2020

Link: https://hdl.handle.net/1..